News

Novavax Collaborates with SK bioscience for COVID-19 Vaccine Candidate

August 13, 2020

SK bioscience will manufacture the vaccine antigen component for use in the final drug product at its vaccine facility in Andong L-house, South Korea.

ANA Therapeutics and Quotient Sciences to Collaborate on Potential COVID-19 Treatment

August 13, 2020

ANA will use Quotient’s formulation and manufacturing knowledge to develop and supply the drug product for clinical trials by the third quarter of 2020.

FDA Approves Roche’s Spinal Muscular Atrophy Drug

August 13, 2020

FDA has approved Evrysdi (risdiplam) for treating spinal muscular atrophy in adults and children.

US Government Awards Moderna $1.5 billion for COVID-19 Vaccine Candidate

August 13, 2020

In combination with BARDA’s previous award, the commitment for early access to Moderna’s vaccine candidate has now reached to up to $2.48 billion.

Henlius and Accord Healthcare Receive European Approval for Biosimilar Trastuzumab

August 13, 2020

The companies received approval from the EC for Zercepac (HLX02), a biosimilar referencing Roche’s originator biologic, Herceptin (trastuzumab).

Colorcon Ventures Invests in AI Solutions Provider

August 13, 2020

Atomwise’s technology, AtomNet, works to eliminate the barriers of physical screening for small molecule drug discovery.

Gilead Submits NDA to FDA for Remdesivir to Treat COVID-19

August 13, 2020

Veklury (remdesivir) is an investigational antiviral drug that Gilead is developing to treat COVID-19.

CHMP Gives Positive Opinion on Centus Biotherapeutics’ Bevacizumab Biosimilar

August 13, 2020

The committee has given a positive opinion on the biosimilar bevacizumab for several cancer indications.

CTS Bioprocessing Acquires Sani-Tech West Companies and Rebrands as SaniSure

August 12, 2020

The companies will work to establish an operational footprint across North America and Europe that will offer customers supply chain assurance for a combined portfolio of leading solutions.

Bayer to Acquire KaNDy Therapeutics for up to $875 Million

August 12, 2020

The company will use the acquisition to further its drug development pipeline in women’s healthcare.